RxDoctor Payments Data

Lynn Webster

Pain Medicine · Salt Lake City, UTNPI 1164420246

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $110,209 of the $160,394 with a category attached, or 68.7%. 12 manufacturers reported payments, led by Mallinckrodt LLC at 32.1% of the total. Reporting peaked in 2019 at $96,654 and has fallen 81.8% since, to $17,603 in 2025. Among pain medicine clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$160,394in general payments, 2019–2025

Across 111 payments — averaging $1444.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt LLC$52K
  • Collegium Pharmaceutical, Inc.$33K
  • Biodelivery Sciences International, Inc.$18K
  • Shionogi Inc$14K
  • Daiichi Sankyo Inc.$12K
  • Lexicon Pharmaceuticals, Inc.$10K
  • plus $22K from 6 others
$2,606,463in research payments, 2019–2025

Across 35 payments — averaging $74,470 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biodelivery Sciences International, Inc.$1.2M
  • Vertex$768K
  • Merck$608K
  • Janssen Research & Development, LLC$26K

What the payments were for

  • Consulting fees$110,20969%
  • Speaking & faculty fees$30,63519%
  • Travel & lodging$16,45210%
  • Food & beverage$3,0992%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$160,394 in reported general payments places this provider in the 95th percentile of 61 pain medicine providers in Utah.

See all pain medicine providers in Utah

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide12$11,173
Levothyroxine Sodium12$41

Paid to pharmacies, not to this prescriber.

Other pain medicine in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →